Market by Product and Service, Type, Application, Technology, Industry Vertical, and Country Outlook | Forecast 2024-2032
Triton’s research report infers that the multiplex assay market in North America is projected to advance in revenue at a CAGR of 8.53% over the forecasted period 2024-2032.
Report scope can be customized per your requirements - Request Free Sample Report
The
countries in the region include:
• United
States
• Canada
The North American market is witnessing growth
primarily due to heightened research and development efforts focusing on new
drugs, diagnostics, and treatments, alongside a notable increase in chronic
diseases like cancer and strokes. Additionally, government investment in the
discovery of new biomarkers is a significant driver for the expansion of
multiplex assays in the region.
The
United States dominates the market with
the highest share. The
multiplex assay market is witnessing growth in the United States for various
reasons, notably propelled by the escalating incidence of new cancer cases. The
surge in demand for multiplex assays stems from their capability to identify
multiple pathogens, assess disease effectiveness, and facilitate antibody
detection across various diseases. This heightened necessity arises from the
substantial burden of cancer, underlining the utility of multiplex assays in
medical diagnostics.
The advancement of the multiplex assays market in Canada has been greatly
influenced by research and development (R&D) activities. Collaborative
efforts between academic institutions, research organizations, and industry
stakeholders, alongside increased investments from both private and public
sectors, have spurred the innovation of new multiplex assay technologies.
Multiplex assays play a vital role in hospital settings by facilitating
swift disease diagnosis and personalized treatment strategies through companion
diagnostics. With the widespread adoption of multiplex assays, it’s now
possible to identify 20 or more pathogens in under an hour, streamlining the
diagnostic process significantly. The
market is segmented into industry vertical, technology, type, application, and
product and service. Based on industry vertical, it is categorized into
hospitals, clinical laboratory, research institutes, and pharmaceutical &
biotechnology companies.
The notable companies in the market
comprise Agilent Technologies Inc, Becton, Dickinson and Company, Bio-Techne
Corporation, F. Hoffmann-la Roche Ltd, and Bio-Rad Laboratories Inc.
Agilent Technologies Inc specializes in a comprehensive range of
instruments, software, services, and consumables designed to analyze and
characterize biological and physical properties of substances and products. Its
clientele spans clinical diagnostics, analytical laboratories, and various market
sectors. Its operational footprint includes manufacturing facilities and R&D
centers across Europe, Asia-Pacific, and North America, with its headquarters
situated in Santa Clara, California, US.
KEY
DELIVERABLES OF THE REPORT:
●
Market CAGR during the forecasting years 2024-2032
●
Detailed data highlighting key insights, industry components, and
market strategies
●
Comprehensive information and estimation of the multiplex assay market
revenue growth in North America and its influence on the parent market
●
In-depth study of forthcoming trends in consumer behavioral
patterns
●
A meticulous analysis of the competitive landscape and Porter’s
Five Forces
●
A wide-ranging study of factors that will challenge the North
America multiplex assay market’s growth during the upcoming years
Want to get specific insights? Our team of
analysts can customize this report based on your preferences. Connect with us here.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. NORTH
AMERICA MULTIPLEX ASSAY MARKET- SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
ANALYSIS ON THE MULTIPLEX ASSAY MARKET
2.1.1. IMPACT
OF COVID-19 ON THE MULTIPLEX ASSAY MARKET
2.2. PORTER’S
FIVE FORCES MODEL
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTE PRODUCTS
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. COMPETITIVE
RIVALRY
2.3. KEY
BUYING IMPACT ANALYSIS
2.3.1. ANALYTE
COVERAGE
2.3.2. SPEED
2.3.3. MULTIPLEXING
CAPABILITY
2.3.4. EASE
OF USE
2.3.5. AUTOMATION
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. KEY
MARKET STRATEGIES
2.5.1. CONTRACTS
AND PARTNERSHIPS
2.5.2. BUSINESS
EXPANSIONS & DIVESTITURES
2.5.3. ACQUISITIONS
& MERGERS
2.5.4. PRODUCT
LAUNCHES & DEVELOPMENTS
2.6. MARKET
DRIVERS
2.6.1. ADOPTION
OF PERSONALIZED MEDICINES
2.6.2. HIGH
ADOPTION OF MULTIPLEX ASSAYS OVER TRADITIONAL METHODS
2.6.3. INCREASING
PREVALENCE OF CHRONIC DISEASES
2.7. MARKET
CHALLENGES
2.7.1. ISSUES
RELATED TO CROSS-REACTIVITY AND ASSAY INTERFERENCE
2.7.2. CHALLENGE
IN ACHIEVING ADEQUATE ASSAY RANGE
2.7.3. DEARTH
OF SKILLED PROFESSIONALS
2.8. MARKET
OPPORTUNITIES
2.8.1. TECHNOLOGICAL
ADVANCEMENTS IN ASSAY PLATFORMS
2.8.2. RAPID
GROWTH OF COMPANION DIAGNOSTICS
2.8.3. GROWTH
IN DRUG DISCOVERY INITIATIVES
2.9. ANALYST
PERSPECTIVE
3. NORTH
AMERICA MULTIPLEX ASSAY MARKET - BY PRODUCT AND SERVICE
3.1. REAGENTS
AND CONSUMABLES
3.2. INSTRUMENTS
AND ACCESSORIES
3.3. SOFTWARE
AND SERVICES
4. NORTH
AMERICA MULTIPLEX ASSAY MARKET - BY TYPE
4.1. PROTEIN-BASED
MULTIPLEX ASSAY
4.2. NUCLEIC
ACID-BASED MULTIPLEX ASSAY
4.3. OTHER
MULTIPLEX ASSAYS
5. NORTH
AMERICA MULTIPLEX ASSAY MARKET - BY APPLICATION
5.1. RESEARCH
AND DEVELOPMENT
5.2. CLINICAL
DIAGNOSTICS
5.3. COMPANION
DIAGNOSTICS
6. NORTH
AMERICA MULTIPLEX ASSAY MARKET - BY TECHNOLOGY
6.1. MULTIPLEX
PROTEIN MICROARRAY
6.2. MULTIPLEX
PCR
6.3. OTHER
TECHNOLOGIES
7. NORTH
AMERICA MULTIPLEX ASSAY MARKET - BY INDUSTRY VERTICAL
7.1. PHARMACEUTICAL
& BIOTECHNOLOGY COMPANIES
7.2. RESEARCH
INSTITUTES
7.3. CLINICAL
LABORATORIES
7.4. HOSPITALS
8. NORTH
AMERICA MULTIPLEX ASSAY MARKET – BY COUNTRY OUTLOOK
8.1. UNITED
STATES
8.1.1. UNITED
STATES MULTIPLEX ASSAY MARKET FORECAST & PROSPECTS
8.2. CANADA
8.2.1. CANADA
MULTIPLEX ASSAY MARKET FORECAST & PROSPECTS
9. COMPETITIVE
LANDSCAPE
9.1. ABCAM
LIMITED
9.1.1. OVERVIEW
9.1.2. PRODUCT
PORTFOLIO
9.2. AGILENT
TECHNOLOGIES INC
9.2.1. OVERVIEW
9.2.2. PRODUCT
PORTFOLIO
9.2.3. KEY
STRENGTHS
9.2.4. KEY
CHALLENGES
9.3. BECTON,
DICKINSON AND COMPANY (BD)
9.3.1. OVERVIEW
9.3.2. PRODUCT
PORTFOLIO
9.3.3. KEY
STRENGTHS
9.3.4. KEY
CHALLENGES
9.4. BIO-RAD
LABORATORIES INC
9.4.1. OVERVIEW
9.4.2. PRODUCT
PORTFOLIO
9.4.3. KEY
STRENGTHS
9.4.4. KEY
CHALLENGES
9.5. BIO-TECHNE
CORPORATION
9.5.1. OVERVIEW
9.5.2. PRODUCT
PORTFOLIO
9.6. F.
HOFFMANN-LA ROCHE LTD
9.6.1. OVERVIEW
9.6.2. PRODUCT
PORTFOLIO
9.6.3. KEY STRENGTHS
9.6.4. KEY CHALLENGES
9.7. ILLUMINA
INC
9.7.1. OVERVIEW
9.7.2. PRODUCT
PORTFOLIO
9.7.3. KEY STRENGTHS
9.7.4. KEY CHALLENGES
9.8. MERCK
MILLIPORE
9.8.1. OVERVIEW
9.8.2. PRODUCT
PORTFOLIO
9.9. OLINK
PROTEOMICS AB
9.9.1. OVERVIEW
9.9.2. PRODUCT
PORTFOLIO
9.10. QIAGEN
NV
9.10.1. OVERVIEW
9.10.2. PRODUCT
PORTFOLIO
9.10.3. KEY STRENGTHS
9.10.4. KEY CHALLENGES
9.11. RANDOX
LABORATORIES LTD
9.11.1. OVERVIEW
9.11.2. PRODUCT
PORTFOLIO
9.12. SEEGENE
INC
9.12.1. OVERVIEW
9.12.2. PRODUCT
PORTFOLIO
9.13. SIEMENS
HEALTHINEERS AG
9.13.1. OVERVIEW
9.13.2. PRODUCT
PORTFOLIO
9.13.3. KEY
STRENGTHS
9.13.4. KEY
CHALLENGES
9.14. THERMO
FISHER SCIENTIFIC INC
9.14.1. OVERVIEW
9.14.2. PRODUCT
PORTFOLIO
9.14.3. KEY
STRENGTHS
9.14.4. KEY
CHALLENGES
10. RESEARCH
METHODOLOGY & SCOPE
10.1. RESEARCH
SCOPE & DELIVERABLES
10.2. SOURCES
OF DATA
10.3. RESEARCH
METHODOLOGY
TABLE
1: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY COUNTRY OUTLOOK, HISTORICAL YEARS,
2020-2023 (IN $ MILLION)
TABLE
2: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY COUNTRY OUTLOOK, FORECAST YEARS,
2024-2032 (IN $ MILLION)
TABLE
3: CONTRACTS AND PARTNERSHIPS
TABLE
4: LIST OF BUSINESS EXPANSIONS & DIVESTITURES
TABLE
5: ACQUISITIONS & MERGERS
TABLE
6: LIST OF NEW PRODUCT LAUNCHES & DEVELOPMENTS
TABLE
7: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY PRODUCT AND SERVICE, 2024-2032 (IN
$ MILLION)
TABLE
8: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY TYPE, 2024-2032 (IN $ MILLION)
TABLE
9: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2024-2032 (IN $
MILLION)
TABLE
10: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2024-2032 (IN $
MILLION)
TABLE
11: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY INDUSTRY VERTICAL, 2024-2032 (IN $
MILLION)
TABLE
12: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)
FIGURE
1: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY PRODUCT AND SERVICE, 2023 &
2032 (IN %)
FIGURE
2: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY REAGENTS AND CONSUMABLES, 2024-2032
(IN $ MILLION)
FIGURE
3: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY INSTRUMENTS AND ACCESSORIES,
2024-2032 (IN $ MILLION)
FIGURE
4: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY SOFTWARE AND SERVICES, 2024-2032
(IN $ MILLION)
FIGURE
5: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY TYPE, 2023 & 2032 (IN %)
FIGURE
6: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY PROTEIN-BASED MULTIPLEX ASSAY,
2024-2032 (IN $ MILLION)
FIGURE
7: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY NUCLEIC ACID-BASED MULTIPLEX ASSAY,
2024-2032 (IN $ MILLION)
FIGURE
8: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY OTHER MULTIPLEX ASSAYS, 2024-2032
(IN $ MILLION)
FIGURE
9: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2023 & 2032 (IN %)
FIGURE
10: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY RESEARCH AND DEVELOPMENT,
2024-2032 (IN $ MILLION)
FIGURE
11: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY CLINICAL DIAGNOSTICS, 2024-2032
(IN $ MILLION)
FIGURE
12: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY COMPANION DIAGNOSTICS, 2024-2032
(IN $ MILLION)
FIGURE
13: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2023 & 2032 (IN %)
FIGURE
14: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY MULTIPLEX PROTEIN MICROARRAY,
2024-2032 (IN $ MILLION)
FIGURE
15: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY MULTIPLEX PCR, 2024-2032 (IN $
MILLION)
FIGURE
16: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY OTHER TECHNOLOGIES, 2024-2032 (IN
$ MILLION)
FIGURE
17: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY INDUSTRY VERTICAL, 2023 & 2032
(IN %)
FIGURE
18: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY
COMPANIES, 2024-2032 (IN $ MILLION)
FIGURE
19: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY RESEARCH INSTITUTES, 2024-2032 (IN
$ MILLION)
FIGURE
20: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY CLINICAL LABORATORIES, 2024-2032
(IN $ MILLION)
FIGURE
21: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY HOSPITALS, 2024-2032 (IN $
MILLION)
FIGURE
22: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY COUNTRY OUTLOOK, 2023 & 2032
(IN %)
FIGURE
23: UNITED STATES MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)
FIGURE
24: CANADA MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)